137 related articles for article (PubMed ID: 9760202)
1. A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features.
Tabata Y; Isashiki Y; Kamimura K; Nakao K; Ohba N
Hum Genet; 1998 Aug; 103(2):179-82. PubMed ID: 9760202
[TBL] [Abstract][Full Text] [Related]
2. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
[TBL] [Abstract][Full Text] [Related]
3. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
Li Z; Clarke MP; Barker MD; McKie N
Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
[TBL] [Abstract][Full Text] [Related]
4. Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.
Isashiki Y; Tabata Y; Kamimura K; Ohba N
Jpn J Ophthalmol; 1999; 43(6):472-80. PubMed ID: 10672875
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
[TBL] [Abstract][Full Text] [Related]
6. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.
Langton KP; McKie N; Curtis A; Goodship JA; Bond PM; Barker MD; Clarke M
J Biol Chem; 2000 Sep; 275(35):27027-31. PubMed ID: 10854443
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.
Clarke M; Mitchell KW; Goodship J; McDonnell S; Barker MD; Griffiths ID; McKie N
Br J Ophthalmol; 2001 Dec; 85(12):1429-31. PubMed ID: 11734514
[TBL] [Abstract][Full Text] [Related]
9. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
[TBL] [Abstract][Full Text] [Related]
10. A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.
Felbor U; Stöhr H; Amann T; Schönherr U; Weber BH
Hum Mol Genet; 1995 Dec; 4(12):2415-6. PubMed ID: 8634721
[No Abstract] [Full Text] [Related]
11. [Sorsby's fundus dystrophy. A genetically homogeneous disease].
Felbor U; Weber BH
Ophthalmologe; 1998 May; 95(5):287-90. PubMed ID: 9643018
[TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive Sorsby fundus dystrophy revisited: molecular evidence for dominant inheritance.
Felbor U; Suvanto EA; Forsius HR; Eriksson AW; Weber BH
Am J Hum Genet; 1997 Jan; 60(1):57-62. PubMed ID: 8981947
[TBL] [Abstract][Full Text] [Related]
13. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
Sieving PA; Boskovich S; Bingham E; Pawar H
Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene.
Ayyagari R; Griesinger IB; Bingham E; Lark KK; Moroi SE; Sieving PA
Arch Ophthalmol; 2000 Jan; 118(1):85-92. PubMed ID: 10636420
[TBL] [Abstract][Full Text] [Related]
15. Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.
Peters AL; Greenberg J
Retina; 1995; 15(6):480-5. PubMed ID: 8747441
[TBL] [Abstract][Full Text] [Related]
16. [Sorsby's fundus dystrophy: a literature review].
Isashiki Y; Ohba N
Nippon Ganka Gakkai Zasshi; 1999 Jan; 103(1):3-11. PubMed ID: 10036918
[TBL] [Abstract][Full Text] [Related]
17. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal p.(Ser38Cys) TIMP3 mutation underlying Sorsby fundus dystrophy is a founder mutation disrupting an intramolecular disulfide bond.
Naessens S; De Zaeytijd J; Syx D; Vandenbroucke RE; Smeets F; Van Cauwenbergh C; Leroy BP; Peelman F; Coppieters F
Hum Mutat; 2019 May; 40(5):539-551. PubMed ID: 30668888
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy.
Fogarasi M; Janssen A; Weber BH; Stöhr H
Matrix Biol; 2008 Jun; 27(5):381-92. PubMed ID: 18295466
[TBL] [Abstract][Full Text] [Related]
20. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
